Gall stone causes

Reading File
Finding Sources
Searching PubMed

cholelithiasis pathogenesis risk factors

Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Here is a complete, textbook-grounded answer on gallstone causes:

Gallstone Causes (Cholelithiasis)

Cholesterol gallstones in an opened gallbladder with thickened, fibrotic wall from chronic cholecystitis
Gallstones affect 10-20% of adults in Western countries and about 1 million new cases are diagnosed annually in the United States. There are two fundamentally different types of stones, each with distinct causes.

1. Cholesterol Stones (80% in the West)

Cholesterol is solubilized in bile by bile salts and lecithins. When cholesterol concentration exceeds the solubilizing capacity of bile - a state called supersaturation - cholesterol crystallizes out of solution. Three interacting mechanisms drive this:

A. Bile Supersaturation with Cholesterol

  • Obesity and metabolic syndrome - increase hepatic cholesterol secretion into bile
  • Rapid weight loss - mobilizes peripheral cholesterol that floods into bile
  • Insulin resistance - alters bile acid metabolism
  • Estrogens - increase hepatic cholesterol uptake and synthesis, causing excess biliary cholesterol secretion

B. Crystal Nucleation and Growth

  • Once supersaturated, cholesterol crystals nucleate faster than they can be flushed out
  • Mucus hypersecretion traps crystals, enhancing aggregation into stones

C. Gallbladder Hypomotility / Stasis

Any condition that reduces gallbladder emptying promotes stone formation:
  • Pregnancy - progesterone slows smooth muscle motility; estrogens also increase bile lithogenicity
  • Prolonged fasting / total parenteral nutrition (TPN) - gallbladder isn't stimulated by CCK
  • Vagotomy - disrupts neural control of gallbladder contraction
  • Spinal cord injury

2. Pigment Stones (Predominantly in Asia and developing countries)

These are made of insoluble calcium bilirubinate salts. They form when bile contains excess unconjugated bilirubin.

Black Pigment Stones (found in sterile gallbladder bile)

Caused by conditions producing chronic hemolysis, which floods the bile with unconjugated bilirubin:
  • Sickle cell anemia - by age 10, at least 14% of children have gallstones; 36% by age 10-20
  • Hereditary spherocytosis
  • Thalassemia
  • Cirrhosis - reduced bile salt synthesis impairs bilirubin solubilization

Brown Pigment Stones (found in infected biliary ducts)

Caused by biliary infection - bacteria (e.g., E. coli, liver flukes like Clonorchis sinensis) produce phospholipases that release fatty acids from lecithins, forming calcium soaps. Common in Asia.

Summary Table of Risk Factors

CategoryCholesterol StonesPigment Stones
DemographicsNorthern Europeans, Native Americans, North/South AmericansAsian, non-Western populations
AgeAdvancing age (>80 yrs: 25-30%)Any age
Sex/HormonesFemale sex, oral contraceptives, pregnancy-
MetabolicObesity, insulin resistance, rapid weight loss-
Hemolysis-Sickle cell, spherocytosis, thalassemia
GI disordersIleal disease (Crohn), ileal resection (disrupts bile acid enterohepatic cycling)Crohn disease, ileal resection, cystic fibrosis
HepaticInborn errors of bile acid metabolism, dyslipidemia syndromesCirrhosis
Infection-Biliary infection, liver flukes
Genetic~25% heritable; ABCB4, ABCG5/G8 mutationsUGT1A1 polymorphism (Gilbert syndrome)
IatrogenicTPN, prolonged fasting, fibrates (increase cholesterol secretion)-

Key Pathogenesis Summary

  • Cholesterol stones = bile supersaturation + nucleation + stasis
  • Pigment stones = excess unconjugated bilirubin (hemolysis) or biliary infection (bacteria hydrolyze conjugated bilirubin)
Sources: Robbins & Kumar Basic Pathology, p. 630; Robbins, Cotran & Kumar Pathologic Basis of Disease, Table 18.11; Sleisenger and Fordtran's Gastrointestinal and Liver Disease, Table 62.2

Recent evidence note: A 2026 Mendelian randomization meta-analysis (PMID 40064441) found causal links between gastrointestinal inflammation and gallstone formation, supporting the known association with inflammatory bowel disease. A 2025 systematic review (PMID 40499738) confirmed GLP-1 receptor agonists (e.g., semaglutide) are associated with gallstone and cholecystitis risk - likely through rapid weight loss and altered gallbladder motility - an increasingly relevant cause given widespread use of these drugs.
This is a shared conversation. Sign in to Orris to start your own chat.